Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 23, 2023 - Issue 10
Submit an article Journal homepage
1,248
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Inebilizumab for neuromyelitis optica spectrum disorders in Italy: a budget impact model

Carlo Lazzaroa Studio di Economia Sanitaria, Milan, Italy;b Biology and Biotechnologies Department “Lazzaro Spallanzani”, University of Pavia, Pavia, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4795-1834View further author information
ORCID Icon,
Nicola Amedeo Mazzantic Horizon Therapeutics Italy S.r.l, Milan, ItalyView further author information
,
Silvia Rossic Horizon Therapeutics Italy S.r.l, Milan, ItalyView further author information
&
Fabio Parazzinid Department of Clinical Sciences and Community Health (DISCCO), University of Milan, Milan, ItalyView further author information
Pages 1185-1200 | Received 15 Jun 2023, Accepted 01 Oct 2023, Published online: 17 Oct 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.